Craig Chambliss is the founder of Neurelis. Neurelis has raised $300M in total funding. Based in San Diego, CA.
Craig Chambliss is the CEO and Co-founder of Neurelis, a pharmaceutical company he established in 2007. Neurelis focuses on developing treatments for CNS diseases, with an emphasis on epilepsy. He has secured over $300 million in funding to support Neurelis's growth from early development to commercialization, including the launch of VALTOCO for seizure clusters.
Full founder directory · Investor directory · Company funding database · Fundraising library